Filter posts

DEA Drug Take Back Day Breaks Collection Record

Last week, the Drug Enforcement Administration’s 14th Prescription Drug Take Back Day collected a record-setting …

Insurers Distort the Facts on Drug Costs … Again

An effort by the Blue Cross Blue Shield Association (BCBSA) to spur a discussion on …

Biotech Faces Up to Our Own Leadership Diversity Challenge

Disease is an equal-opportunity enemy. It strikes men and women; children and seniors; and people …

A New Approach to Assessing Value in Health Care

It’s an important and exciting time in the biotech industry. Spending on prescription drugs has …

The Risky Business of Drug Importation

You hear it all the time: prescription drugs in the United States are too expensive, …

Celebrating One Health Day

Today, on the 2nd annual One Health Day, it’s important for us to recognize the …

Jim Greenwood Talks Biotech Innovation With Bloomberg Radio

While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau …

Biomedical Innovation Can Help Solve the Opioid Crisis

Opioid abuse in America touches the lives of millions. It’s estimated that more than 1,000 …

ICYMI: Reducing Regulatory Hurdles Can Help Boost Innovation

Featured this week in the Wall Street Journal, columnist Greg Ip discusses how reducing regulatory hurdles …

A Flawed Bill That Would Harm Seniors

The Medicare prescription drug program has been a remarkable success for both seniors and taxpayers, …